Callan JMB

Callan JMB EV/EBITDA

The EV/EBITDA (Enterprise Value to EBITDA) of Callan JMB (CJMB) as of Oct 27, 2026 is -1.03. In the previous year, EV/EBITDA (Enterprise Value to EBITDA) was -2.46 — a change of -58.33% (higher).

EV/EBITDA

-1.03

YoY

-58.33%

Last updated:

EV/EBITDA (Enterprise Value to EBITDA) of Callan JMB is 2025 -1.03 . EV/EBITDA (Enterprise Value to EBITDA) of Callan JMB was 2024 -2.46 . It decreases by -58.33% higher compared to the previous year.

The Callan JMB EV/EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EV/EBITDA
Date
EV/EBITDA
Jan 1, 2022
0.16 USD
Jan 1, 2023
0.93 USD
Jan 1, 2024
-2.46 USD
Jan 1, 2025
-1.03 USD
The Callan JMB EV/EBITDA history
YEAREV/EBITDAYoY
-1.03-58.33%
-2.46-365.96%
0.93+475.98%
0.16—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Callan JMB Stock analysis

What does Callan JMB do? Callan JMB Inc provides thermal management logistics solutions for the life sciences industry, including personalized medicine, cell therapies, and vaccines. The company's Ship2Q ultraviolet disinfection process ensures thermal reliability and cleanliness of packaging systems. Its vertically integrated model combines proprietary packaging, IT, and cold chain logistics expertise to serve clients requiring cryogenic or frozen shipping. The firm targets life sciences companies needing specialized shipping solutions for temperature-sensitive products. Callan JMB Inc's primary products include thermal management logistics services and the Ship2Q disinfection process. These solutions address the full range of frozen shipping needs in the life sciences sector. The company serves manufacturers of biopharmaceuticals, diagnostic materials, and other temperature-sensitive commodities. Its services ensure that shipping systems meet manufacturer specifications for fitness and thermal performance. The company's business model focuses on providing comprehensive alternatives to traditional logistics solutions for frozen shipping. It operates as a vertically integrated provider, handling all aspects of cold chain logistics from packaging to delivery. Callan JMB Inc's target clients are life sciences companies requiring reliable, temperature-controlled shipping for sensitive materials like cell lines, cord blood, and organs. The firm's proprietary technology differentiates it in the specialized logistics market. Callan JMB is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Callan JMB stock

EV/EBITDA (Enterprise Value to EBITDA) of Callan JMB is -1.03 in 2025.

EV/EBITDA (Enterprise Value to EBITDA) of Callan JMB changed from -2.46 to -1.03, representing a -58.33% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EV/EBITDA (Enterprise Value to EBITDA) Callan JMB since 2006 – with annual values, charts, and detailed analysis.

The EV/EBITDA ratio is a widely used valuation metric that compares a company's enterprise value to its EBITDA. It normalizes for differences in capital structure, taxation, and depreciation policies.

To evaluate EV/EBITDA (Enterprise Value to EBITDA)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EV/EBITDA (Enterprise Value to EBITDA).

A 'good' varies by industry and company stage. On Eulerpool, you can compare EV/EBITDA (Enterprise Value to EBITDA)'s Callan JMB with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Callan JMB

All Key Metrics — Callan JMB